Multi-agency report highlights importance of reducing antibiotic use 22 February 2024 All news https://www.ema.europa.eu/en/news/multi-agency-report-highlights-importance-reducing-antibiotic-use
Annual report on the use of the special contribution for orphan medicinal products 19 February 2024 All news annual-report-use-special-contribution-orphan-medicinal-products-2023_en-1Download
GD decision no. 2024-99 of 25/01/2024 – Changes to the organisational structure of the ANSM 9 February 2024 All news https://ansm.sante.fr/actualites/decision-dg-ndeg-2024-99-du-25-01-2024-modification-de-lorganisation-de-lansm
Clinical trial’s transition to new EU system – one year left 5 February 2024 All news https://www.ema.europa.eu/en/news/clinical-trials-transition-new-eu-system-one-year-left
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 January 2024 2 February 2024 All news https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-january-2024
Major update of the SME user guide 29 January 2024 All news https://www.ema.europa.eu/en/news/major-update-sme-user-guide
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 January 2024 25 January 2024 All news https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-janvier-2024-8-11-janvier
Clinical trials on medicinal products: all transition applications must be submitted via the CTIS portal 22 January 2024 All news https://ansm.sante.fr/actualites/essais-cliniques-de-medicaments-toutes-les-demandes-de-transition-doivent-etre-deposees-sur-le-portail-ctis
